Dr. Nicholas D Klemen, M.D.
Claim this profileStudies Cholangiocarcinoma
Studies Liver Cancer
1 reported clinical trial
1 drug studied
Area of expertise
1Cholangiocarcinoma
Stage IV
Stage I
Stage II
2Liver Cancer
Stage IV
Stage I
Stage II
More about Nicholas D Klemen, M.D.
Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Nicholas D Klemen, M.D. has experience with
- KRAS TCR-Transduced PBL
Breakdown of trials Nicholas D Klemen, M.D. has run
Cholangiocarcinoma
Liver Cancer
Hepatocellular Carcinoma
Duodenal Cancer
Stomach Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nicholas D Klemen, M.D. specialize in?
Nicholas D Klemen, M.D. focuses on Cholangiocarcinoma and Liver Cancer. In particular, much of their work with Cholangiocarcinoma has involved Stage IV patients, or patients who are Stage I.
Is Nicholas D Klemen, M.D. currently recruiting for clinical trials?
No, Nicholas D Klemen, M.D. is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Nicholas D Klemen, M.D. has studied deeply?
Yes, Nicholas D Klemen, M.D. has studied treatments such as KRAS TCR-Transduced PBL.
What is the best way to schedule an appointment with Nicholas D Klemen, M.D.?
Apply for one of the trials that Nicholas D Klemen, M.D. is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.